US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spero Therapeutics Inc.

2.34

+0.02000.86%

Volume:97.81K

Turnover:226.89K

Market Cap:131.83M

PE:-2.96

High:2.35

Open:2.33

Low:2.31

Close:2.32

52wk High:3.22

52wk Low:0.5052

Shares:56.34M

Float Shares:45.80M

Volume Ratio:0.65

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7905

EPS(LYR):-1.2688

ROE:-95.29%

ROA:-29.77%

PB:4.98

PE(LYR):-1.84

Loading ...

Overview Company News Filings

Spero Therapeutics announces inducement grant under Nasdaq listing rule

Spero Therapeutics Grants 90,000 RSUs to New Employee Under Inducement Plan

Spero Therapeutics Q3 net loss narrows

BRIEF-Spero Therapeutics Q3 EPS USD -0.13

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

THOMSON REUTERS

Spero Therapeutics Reports Phase 3 Success for Oral Antibiotic Tebipenem HBr in cUTI Treatment

BRIEF-GSK Announces Full Results Of Positive Pivotal Phase III PIVOT-PO Trial Evaluating Tebipenem HBr

GSK: to Work With U.S. Authorities to Include Tebipenem Hbr Data as Part of Filing in Q4

THOMSON REUTERS

GSK: Data Show Tebipenem Hbr’s Potential as First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections

THOMSON REUTERS

GSK: Full Results of Positive Pivotal Phase Iii Pivot-Po Trial Evaluating Tebipenem Hbr

THOMSON REUTERS

GSK: Safety Profile of Tebipenem Hbr Generally Similar to Imipenem-Cilastatin & Other Carbapenem Antibiotics

THOMSON REUTERS

GSK: Trial Primary Endpoint Met, Showing Non-Inferiority of Oral Tebipenem Hbr VS Iv Treatment

THOMSON REUTERS

Spero Therapeutics Announces Positive Phase 3 PIVOT-PO Trial Results for Oral Tebipenem in Complicated Urinary Tract Infections at IDWeek 2025

Director Ankit Mahadevia Reports Disposal of Common Shares of Spero Therapeutics Inc

Timothy Keutzer, Chief Operating Officer, Reports Disposal of Spero Therapeutics Inc. Common Shares

Spero Therapeutics Q2 EPS $(0.03) Beats $(0.38) Estimate, Sales $14.189M Up From $10.197M YoY

BRIEF-Spero Therapeutics Q2 EPS USD -0.03

Spero Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Spero Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Spero Therapeutics Inc. Conducted Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SPRO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRO\",,,,,undefined,":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":2.34,"timestamp":1765820818486,"preClose":2.32,"halted":0,"volume":97807,"delay":0,"floatShares":45804555,"shares":56339295,"eps":-0.790454,"marketStatus":"Trading","change":0.02,"latestTime":"12-15 12:47:24 EST","open":2.33,"high":2.35,"low":2.305,"amount":226890.8007056,"amplitude":0.019397,"askPrice":2.34,"askSize":498,"bidPrice":2.33,"bidSize":240,"shortable":3,"etf":0,"ttmEps":-0.790454,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1509595200000,"exchange":"NASDAQ","adjPreClose":2.32,"preHourTrading":{"tag":"盘前","latestPrice":2.3113,"preClose":2.32,"latestTime":"09:05 EST","volume":662,"amount":1531.399966,"timestamp":1765807523693},"postHourTrading":{"tag":"盘后","latestPrice":2.32,"preClose":2.32,"latestTime":"19:21 EST","volume":664,"amount":1537.12,"timestamp":1765585304801},"volumeRatio":0.64964,"impliedVol":0.5679,"impliedVolPercentile":0.316},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRO\",,,,,undefined,":{"symbol":"SPRO","floatShares":45804555,"roa":"-29.77%","roe":"-95.29%","lyrEps":-1.268849,"volumeRatio":0.64964,"shares":56339295,"dividePrice":0,"high":2.35,"amplitude":0.019397,"preClose":2.32,"low":2.305,"week52Low":0.5052,"pbRate":"4.98","psRate":"3.25","week52High":3.22,"institutionHeld":0.1648,"latestPrice":2.34,"committee":-0.349593,"eps":-0.790454,"divideRate":0,"volume":97807,"delay":0,"ttmEps":-0.790454,"open":2.33,"prevYearClose":1.03,"prevWeekClose":2.32,"prevMonthClose":2.4,"prevQuarterClose":1.88,"fiveDayClose":2.31,"twentyDayClose":2.41,"sixtyDayClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"SPRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-08-12","symbol":"SPRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-05-13","symbol":"SPRO","fiscalQuarterEnding":"2025/03","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-03-27","symbol":"SPRO","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-11-14","symbol":"SPRO","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1743138000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRO","date":"2025-12-12","current":-2.935022,"percent":0.399194,"low":-57.13681,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"high":19.398721,"avg":-3.855619,"sd":12.484514,"marketCap":132397343},"quantilePoints":[{"date":"2020-12-18","current":-5.682722,"twenty":-5.192208,"median":-4.4074,"eighty":-3.350803,"marketCap":481218555},{"date":"2020-12-24","current":-7.053638,"twenty":-5.214007,"median":-4.442633,"eighty":-3.354954,"marketCap":597309133},{"date":"2020-12-31","current":-6.225309,"twenty":-5.234162,"median":-4.446594,"eighty":-3.354954,"marketCap":527165411},{"date":"2021-01-08","current":-5.368085,"twenty":-5.261058,"median":-4.450379,"eighty":-3.366119,"marketCap":454574816},{"date":"2021-01-15","current":-5.2814,"twenty":-5.270013,"median":-4.459539,"eighty":-3.373929,"marketCap":447234194},{"date":"2021-01-22","current":-6.032675,"twenty":-5.279365,"median":-4.463316,"eighty":-3.381717,"marketCap":510852918},{"date":"2021-01-29","current":-5.814355,"twenty":-5.288101,"median":-4.468542,"eighty":-3.384207,"marketCap":492365425},{"date":"2021-02-05","current":-6.411523,"twenty":-5.305613,"median":-4.476068,"eighty":-3.385101,"marketCap":542934155},{"date":"2021-02-12","current":-6.533525,"twenty":-5.332316,"median":-4.488361,"eighty":-3.38727,"marketCap":553265401},{"date":"2021-02-19","current":-6.594526,"twenty":-5.345052,"median":-4.491045,"eighty":-3.388835,"marketCap":558431024},{"date":"2021-02-26","current":-5.833619,"twenty":-5.361227,"median":-4.491318,"eighty":-3.396406,"marketCap":493996675},{"date":"2021-03-05","current":-5.246083,"twenty":-5.368258,"median":-4.500168,"eighty":-3.402401,"marketCap":444243570},{"date":"2021-03-12","current":-6.309418,"twenty":-5.371976,"median":-4.50969,"eighty":-3.412251,"marketCap":493901262},{"date":"2021-03-19","current":-5.981509,"twenty":-5.387929,"median":-4.516354,"eighty":-3.419748,"marketCap":468232558},{"date":"2021-03-26","current":-5.205082,"twenty":-5.390332,"median":-4.5202,"eighty":-3.42079,"marketCap":407453789},{"date":"2021-04-01","current":-5.382228,"twenty":-5.390408,"median":-4.521243,"eighty":-3.420837,"marketCap":421320789},{"date":"2021-04-09","current":-4.92994,"twenty":-5.390015,"median":-4.533574,"eighty":-3.422527,"marketCap":385915681},{"date":"2021-04-16","current":-4.873404,"twenty":-5.388431,"median":-4.546657,"eighty":-3.425372,"marketCap":381490043},{"date":"2021-04-23","current":-4.96763,"twenty":-5.385512,"median":-4.556667,"eighty":-3.42912,"marketCap":388866107},{"date":"2021-04-30","current":-5.186236,"twenty":-5.384138,"median":-4.561447,"eighty":-3.434848,"marketCap":405978576},{"date":"2021-05-07","current":-5.34766,"twenty":-5.383374,"median":-4.571125,"eighty":-3.437796,"marketCap":398106514},{"date":"2021-05-14","current":-5.550887,"twenty":-5.383374,"median":-4.577339,"eighty":-3.443639,"marketCap":413235748},{"date":"2021-05-21","current":-5.778023,"twenty":-5.388431,"median":-4.581276,"eighty":-3.449286,"marketCap":430144892},{"date":"2021-05-28","current":-5.778023,"twenty":-5.40792,"median":-4.591235,"eighty":-3.449342,"marketCap":430144892},{"date":"2021-06-04","current":-5.662462,"twenty":-5.417705,"median":-4.597317,"eighty":-3.449426,"marketCap":421541994},{"date":"2021-06-11","current":-6.144628,"twenty":-5.434813,"median":-4.599337,"eighty":-3.453071,"marketCap":457436844},{"date":"2021-06-18","current":-5.845765,"twenty":-5.446368,"median":-4.604387,"eighty":-3.468018,"marketCap":435187970},{"date":"2021-06-25","current":-5.944218,"twenty":-5.457323,"median":-4.615778,"eighty":-3.470102,"marketCap":442517290},{"date":"2021-07-02","current":-6.299275,"twenty":-5.46757,"median":-4.61859,"eighty":-3.472876,"marketCap":468949531},{"date":"2021-07-09","current":-6.287307,"twenty":-5.475294,"median":-4.622569,"eighty":-3.474158,"marketCap":468058556},{"date":"2021-07-16","current":-5.756716,"twenty":-5.489092,"median":-4.626391,"eighty":-3.480666,"marketCap":428558691},{"date":"2021-07-23","current":-5.716821,"twenty":-5.500087,"median":-4.638695,"eighty":-3.480666,"marketCap":425588776},{"date":"2021-07-30","current":-5.32187,"twenty":-5.502843,"median":-4.646898,"eighty":-3.488476,"marketCap":396186620},{"date":"2021-08-06","current":-6.019339,"twenty":-5.513362,"median":-4.65834,"eighty":-3.4903,"marketCap":454556416},{"date":"2021-08-13","current":-5.755408,"twenty":-5.525665,"median":-4.663304,"eighty":-3.4903,"marketCap":434625371},{"date":"2021-08-20","current":-6.581258,"twenty":-5.533309,"median":-4.666253,"eighty":-3.49108,"marketCap":496990254},{"date":"2021-08-27","current":-7.219801,"twenty":-5.546817,"median":-4.67971,"eighty":-3.494402,"marketCap":545210525},{"date":"2021-09-03","current":-7.624212,"twenty":-5.552096,"median":-4.686116,"eighty":-3.49605,"marketCap":575750029},{"date":"2021-09-10","current":-7.798748,"twenty":-5.562419,"median":-4.693364,"eighty":-3.499653,"marketCap":588930237},{"date":"2021-09-17","current":-8.152075,"twenty":-5.582179,"median":-4.697982,"eighty":-3.503388,"marketCap":615612120},{"date":"2021-09-24","current":-7.973283,"twenty":-5.594764,"median":-4.710228,"eighty":-3.509466,"marketCap":602110444},{"date":"2021-10-01","current":-7.470962,"twenty":-5.603316,"median":-4.715815,"eighty":-3.514862,"marketCap":564177164},{"date":"2021-10-08","current":-7.270885,"twenty":-5.619957,"median":-4.72441,"eighty":-3.518383,"marketCap":549068146},{"date":"2021-10-15","current":-7.245343,"twenty":-5.64147,"median":-4.72918,"eighty":-3.521658,"marketCap":547139335},{"date":"2021-10-22","current":-7.177232,"twenty":-5.657325,"median":-4.732389,"eighty":-3.522954,"marketCap":541995840},{"date":"2021-10-29","current":-7.475219,"twenty":-5.670933,"median":-4.736196,"eighty":-3.536236,"marketCap":564498633},{"date":"2021-11-05","current":-7.458191,"twenty":-5.687453,"median":-4.740792,"eighty":-3.542421,"marketCap":563212759},{"date":"2021-11-12","current":-6.86102,"twenty":-5.711236,"median":-4.749034,"eighty":-3.563973,"marketCap":542713529},{"date":"2021-11-19","current":-6.742515,"twenty":-5.718593,"median":-4.751989,"eighty":-3.576764,"marketCap":533339680},{"date":"2021-11-26","current":-6.174509,"twenty":-5.742633,"median":-4.762697,"eighty":-3.582625,"marketCap":488409852},{"date":"2021-12-03","current":-5.541121,"twenty":-5.745538,"median":-4.767707,"eighty":-3.588112,"marketCap":438308246},{"date":"2021-12-10","current":-5.569726,"twenty":-5.747863,"median":-4.770134,"eighty":-3.591569,"marketCap":440570899},{"date":"2021-12-17","current":-5.553381,"twenty":-5.745538,"median":-4.78812,"eighty":-3.601982,"marketCap":439277955},{"date":"2021-12-23","current":-5.729095,"twenty":-5.744668,"median":-4.791373,"eighty":-3.610941,"marketCap":453177110},{"date":"2021-12-31","current":-6.542283,"twenty":-5.752225,"median":-4.794534,"eighty":-3.616718,"marketCap":517501108},{"date":"2022-01-07","current":-5.353148,"twenty":-5.753772,"median":-4.807458,"eighty":-3.62158,"marketCap":423439382},{"date":"2022-01-14","current":-5.394012,"twenty":-5.752225,"median":-4.812969,"eighty":-3.626637,"marketCap":426671744},{"date":"2022-01-21","current":-4.740192,"twenty":-5.749384,"median":-4.815545,"eighty":-3.632464,"marketCap":374953957},{"date":"2022-01-28","current":-4.531787,"twenty":-5.746075,"median":-4.808831,"eighty":-3.647672,"marketCap":358468912},{"date":"2022-02-04","current":-4.343814,"twenty":-5.744835,"median":-4.802417,"eighty":-3.65681,"marketCap":343600048},{"date":"2022-02-11","current":-4.106805,"twenty":-5.743655,"median":-4.792518,"eighty":-3.669066,"marketCap":324852350},{"date":"2022-02-18","current":-3.783981,"twenty":-5.74156,"median":-4.791069,"eighty":-3.673506,"marketCap":299316693},{"date":"2022-02-25","current":-3.873881,"twenty":-5.741354,"median":-4.78527,"eighty":-3.672903,"marketCap":306427889},{"date":"2022-03-04","current":-3.518367,"twenty":-5.741354,"median":-4.7699,"eighty":-3.669563,"marketCap":278306342},{"date":"2022-03-11","current":-3.416208,"twenty":-5.737401,"median":-4.767881,"eighty":-3.646094,"marketCap":270225438},{"date":"2022-03-18","current":-3.42438,"twenty":-5.729095,"median":-4.765727,"eighty":-3.615008,"marketCap":270871910},{"date":"2022-03-25","current":-3.330394,"twenty":-5.720811,"median":-4.751989,"eighty":-3.585269,"marketCap":263437478},{"date":"2022-04-01","current":-2.594724,"twenty":-5.718038,"median":-4.749034,"eighty":-3.543147,"marketCap":232892024},{"date":"2022-04-08","current":-2.685959,"twenty":-5.716835,"median":-4.743166,"eighty":-3.523112,"marketCap":241080914},{"date":"2022-04-14","current":-2.229784,"twenty":-5.716824,"median":-4.739876,"eighty":-3.518367,"marketCap":200136465},{"date":"2022-04-22","current":-1.999871,"twenty":-5.713858,"median":-4.736196,"eighty":-3.503388,"marketCap":179500463},{"date":"2022-04-29","current":-1.773609,"twenty":-5.712894,"median":-4.732389,"eighty":-3.490924,"marketCap":159192016},{"date":"2022-05-06","current":-0.755426,"twenty":-5.711236,"median":-4.72918,"eighty":-3.48159,"marketCap":67804007},{"date":"2022-05-13","current":-0.624047,"twenty":-5.702858,"median":-4.72441,"eighty":-3.473837,"marketCap":56012005},{"date":"2022-05-20","current":-0.439054,"twenty":-5.700864,"median":-4.715815,"eighty":-3.449426,"marketCap":45293730},{"date":"2022-05-27","current":-0.394513,"twenty":-5.699193,"median":-4.710228,"eighty":-3.447094,"marketCap":40698714},{"date":"2022-06-03","current":-0.330882,"twenty":-5.690284,"median":-4.702589,"eighty":-3.433305,"marketCap":34134405},{"date":"2022-06-10","current":-0.340426,"twenty":-5.683482,"median":-4.696894,"eighty":-3.422991,"marketCap":35119052},{"date":"2022-06-17","current":-0.298366,"twenty":-5.682255,"median":-4.689296,"eighty":-3.417395,"marketCap":30780043},{"date":"2022-06-24","current":-0.299066,"twenty":-5.678341,"median":-4.684128,"eighty":-3.397857,"marketCap":30852251},{"date":"2022-07-01","current":-0.263242,"twenty":-5.671936,"median":-4.673321,"eighty":-3.386215,"marketCap":27156545},{"date":"2022-07-08","current":-0.262351,"twenty":-5.670421,"median":-4.665101,"eighty":-3.380277,"marketCap":27064645},{"date":"2022-07-15","current":-0.251343,"twenty":-5.668792,"median":-4.662662,"eighty":-3.355763,"marketCap":25929019},{"date":"2022-07-22","current":-0.239603,"twenty":-5.661665,"median":-4.658465,"eighty":-3.345397,"marketCap":24717904},{"date":"2022-07-29","current":-0.232953,"twenty":-5.658189,"median":-4.649834,"eighty":-3.332999,"marketCap":24031934},{"date":"2022-08-05","current":-0.271941,"twenty":-5.656983,"median":-4.638695,"eighty":-3.324822,"marketCap":28053981},{"date":"2022-08-12","current":-0.241477,"twenty":-5.656009,"median":-4.630492,"eighty":-3.298983,"marketCap":27352632},{"date":"2022-08-19","current":-0.304169,"twenty":-5.651859,"median":-4.622849,"eighty":-3.28605,"marketCap":34453796},{"date":"2022-08-26","current":-0.28064,"twenty":-5.646896,"median":-4.61859,"eighty":-3.259567,"marketCap":31788667},{"date":"2022-09-02","current":-0.224976,"twenty":-5.644127,"median":-4.615778,"eighty":-3.246458,"marketCap":25483535},{"date":"2022-09-09","current":-0.346737,"twenty":-5.640585,"median":-4.6058,"eighty":-3.222936,"marketCap":39275574},{"date":"2022-09-16","current":-0.278628,"twenty":-5.637707,"median":-4.599337,"eighty":-3.215126,"marketCap":31560729},{"date":"2022-09-23","current":-0.609885,"twenty":-5.631352,"median":-4.597547,"eighty":-3.190148,"marketCap":69082929},{"date":"2022-09-30","current":-0.619173,"twenty":-5.622753,"median":-4.591235,"eighty":-3.174978,"marketCap":70134954},{"date":"2022-10-07","current":-0.578927,"twenty":-5.619258,"median":-4.581276,"eighty":-3.159693,"marketCap":65576181},{"date":"2022-10-14","current":-0.612981,"twenty":-5.617086,"median":-4.577339,"eighty":-3.153712,"marketCap":69433604},{"date":"2022-10-21","current":-0.585118,"twenty":-5.607799,"median":-4.571125,"eighty":-3.144373,"marketCap":66277531},{"date":"2022-10-28","current":-0.609885,"twenty":-5.605826,"median":-4.563951,"eighty":-3.129215,"marketCap":69082929},{"date":"2022-11-04","current":-0.585118,"twenty":-5.602689,"median":-4.558235,"eighty":-3.117302,"marketCap":66277531},{"date":"2022-11-11","current":-0.750715,"twenty":-5.602457,"median":-4.550515,"eighty":-3.107707,"marketCap":85034954},{"date":"2022-11-18","current":-0.94528,"twenty":-5.602457,"median":-4.53616,"eighty":-3.104599,"marketCap":96821219},{"date":"2022-11-25","current":-0.970555,"twenty":-5.599889,"median":-4.531787,"eighty":-3.094731,"marketCap":99410021},{"date":"2022-12-02","current":-0.970555,"twenty":-5.598514,"median":-4.521243,"eighty":-3.082423,"marketCap":99410021},{"date":"2022-12-09","current":-0.88462,"twenty":-5.594581,"median":-4.519318,"eighty":-3.068818,"marketCap":90608092},{"date":"2022-12-16","current":-0.849235,"twenty":-5.593249,"median":-4.516004,"eighty":-3.045488,"marketCap":86983769},{"date":"2022-12-23","current":-0.80374,"twenty":-5.590343,"median":-4.507828,"eighty":-3.001981,"marketCap":82323924},{"date":"2022-12-30","current":-0.87451,"twenty":-5.587699,"median":-4.500168,"eighty":-2.925595,"marketCap":89572571},{"date":"2023-01-06","current":-0.909895,"twenty":-5.587699,"median":-4.491045,"eighty":-2.881897,"marketCap":93196895},{"date":"2023-01-13","current":-1.010994,"twenty":-5.587699,"median":-4.477497,"eighty":-2.7929,"marketCap":103552106},{"date":"2023-01-20","current":-0.950335,"twenty":-5.587699,"median":-4.466436,"eighty":-2.732909,"marketCap":97338979},{"date":"2023-01-27","current":-0.920005,"twenty":-5.587699,"median":-4.454324,"eighty":-2.67399,"marketCap":94232416},{"date":"2023-02-03","current":-0.960445,"twenty":-5.583235,"median":-4.443439,"eighty":-2.641266,"marketCap":98374500},{"date":"2023-02-10","current":-0.90484,"twenty":-5.583235,"median":-4.402047,"eighty":-2.609436,"marketCap":92679134},{"date":"2023-02-17","current":-0.8644,"twenty":-5.583235,"median":-4.39207,"eighty":-2.581469,"marketCap":88537050},{"date":"2023-02-24","current":-0.763301,"twenty":-5.583235,"median":-4.365586,"eighty":-2.554574,"marketCap":78181840},{"date":"2023-03-03","current":-0.753191,"twenty":-5.583235,"median":-4.351987,"eighty":-2.49002,"marketCap":77146318},{"date":"2023-03-10","current":-0.748136,"twenty":-5.583235,"median":-4.340393,"eighty":-2.435794,"marketCap":76628558},{"date":"2023-03-17","current":-0.687476,"twenty":-5.569418,"median":-4.315732,"eighty":-2.391745,"marketCap":70415432},{"date":"2023-03-24","current":-0.722861,"twenty":-5.553381,"median":-4.306481,"eighty":-2.317441,"marketCap":74039755},{"date":"2023-03-31","current":-1.642338,"twenty":-5.547029,"median":-4.288241,"eighty":-2.269765,"marketCap":76229128},{"date":"2023-04-06","current":-1.642338,"twenty":-5.547029,"median":-4.263777,"eighty":-2.208281,"marketCap":76229128},{"date":"2023-04-14","current":-1.936826,"twenty":-5.538381,"median":-4.208866,"eighty":-2.122491,"marketCap":89897800},{"date":"2023-04-21","current":-1.902847,"twenty":-5.538381,"median":-4.199845,"eighty":-1.995117,"marketCap":88320645},{"date":"2023-04-28","current":-2.016112,"twenty":-5.538381,"median":-4.167033,"eighty":-1.97096,"marketCap":93577827},{"date":"2023-05-05","current":-2.129376,"twenty":-5.538381,"median":-4.134222,"eighty":-1.959479,"marketCap":98835008},{"date":"2023-05-12","current":-2.174682,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":100937880},{"date":"2023-05-19","current":-3.524105,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":94629263},{"date":"2023-05-26","current":-3.426213,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":92000672},{"date":"2023-06-02","current":-3.524105,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":94629263},{"date":"2023-06-09","current":-3.524105,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":94629263},{"date":"2023-06-16","current":-3.073803,"twenty":-5.538381,"median":-4.110891,"eighty":-1.959479,"marketCap":82537746},{"date":"2023-06-23","current":-2.878019,"twenty":-5.538748,"median":-4.106805,"eighty":-1.959479,"marketCap":77280565},{"date":"2023-06-30","current":-2.780127,"twenty":-5.538932,"median":-4.088313,"eighty":-1.959479,"marketCap":74651974},{"date":"2023-07-07","current":-2.799705,"twenty":-5.535376,"median":-4.066769,"eighty":-1.959479,"marketCap":75177692},{"date":"2023-07-14","current":-2.975911,"twenty":-5.533309,"median":-4.057057,"eighty":-1.959479,"marketCap":79909155},{"date":"2023-07-21","current":-2.858441,"twenty":-5.533309,"median":-4.0428,"eighty":-1.959479,"marketCap":76754846},{"date":"2023-07-28","current":-2.721392,"twenty":-5.533309,"median":-4.025839,"eighty":-1.959479,"marketCap":73074820},{"date":"2023-08-04","current":-2.956332,"twenty":-5.533309,"median":-4.014818,"eighty":-1.959479,"marketCap":79383437},{"date":"2023-08-11","current":-7.559414,"twenty":-5.535376,"median":-4.006786,"eighty":-1.959479,"marketCap":76229128},{"date":"2023-08-18","current":-6.976353,"twenty":-5.547877,"median":-4.006786,"eighty":-1.959479,"marketCap":70349545},{"date":"2023-08-25","current":-6.796031,"twenty":-5.557245,"median":-4.006786,"eighty":-1.959479,"marketCap":68531175},{"date":"2023-09-01","current":-7.841574,"twenty":-5.577899,"median":-4.006786,"eighty":-1.959479,"marketCap":79074433},{"date":"2023-09-08","current":-7.00514,"twenty":-5.590343,"median":-4.006107,"eighty":-1.957214,"marketCap":70639827},{"date":"2023-09-15","current":-6.743754,"twenty":-5.600531,"median":-4.008698,"eighty":-1.954949,"marketCap":68004012},{"date":"2023-09-22","current":-6.377814,"twenty":-5.619353,"median":-4.008698,"eighty":-1.954949,"marketCap":64313872},{"date":"2023-09-27","current":-6.325536,"twenty":-5.635165,"median":-4.007465,"eighty":-1.952683,"marketCap":63786709},{"date":"2023-10-06","current":-6.064151,"twenty":-5.656766,"median":-4.006107,"eighty":-1.948153,"marketCap":61150895},{"date":"2023-10-13","current":-5.855042,"twenty":-5.670432,"median":-4.007465,"eighty":-1.948153,"marketCap":59042243},{"date":"2023-10-20","current":-5.724349,"twenty":-5.700864,"median":-4.017086,"eighty":-1.948153,"marketCap":57724336},{"date":"2023-10-27","current":-5.227716,"twenty":-5.700864,"median":-4.025257,"eighty":-1.940491,"marketCap":52716289},{"date":"2023-11-03","current":-5.959596,"twenty":-5.712838,"median":-4.040427,"eighty":-1.938575,"marketCap":60096569},{"date":"2023-11-10","current":-5.489102,"twenty":-5.718038,"median":-4.056342,"eighty":-1.938575,"marketCap":55352103},{"date":"2023-11-17","current":-38.091206,"twenty":-5.738192,"median":-4.064,"eighty":-1.938225,"marketCap":61479207},{"date":"2023-11-24","current":-39.076324,"twenty":-5.745362,"median":-4.0782,"eighty":-1.938225,"marketCap":63069187},{"date":"2023-12-01","current":-37.434462,"twenty":-5.756595,"median":-4.110221,"eighty":-1.938225,"marketCap":60419221},{"date":"2023-12-08","current":-41.374931,"twenty":-5.775828,"median":-4.143107,"eighty":-1.938575,"marketCap":66779139},{"date":"2023-12-15","current":-42.688421,"twenty":-5.801932,"median":-4.180228,"eighty":-1.938575,"marketCap":68899112},{"date":"2023-12-22","current":-44.658656,"twenty":-5.81944,"median":-4.20788,"eighty":-1.938575,"marketCap":72079071},{"date":"2023-12-29","current":-47.94238,"twenty":-5.826574,"median":-4.262087,"eighty":-1.938225,"marketCap":77379002},{"date":"2024-01-05","current":-48.270753,"twenty":-5.837472,"median":-4.288241,"eighty":-1.937875,"marketCap":77908995},{"date":"2024-01-12","current":-47.94238,"twenty":-5.855042,"median":-4.312399,"eighty":-1.937875,"marketCap":77379002},{"date":"2024-01-19","current":-46.300518,"twenty":-5.879021,"median":-4.328063,"eighty":-1.937526,"marketCap":74729036},{"date":"2024-01-26","current":-51.226105,"twenty":-5.88973,"median":-4.348245,"eighty":-1.937875,"marketCap":82678934},{"date":"2024-02-02","current":-51.554478,"twenty":-5.907523,"median":-4.3779,"eighty":-1.937875,"marketCap":83208927},{"date":"2024-02-09","current":-44.330283,"twenty":-5.93365,"median":-4.402487,"eighty":-1.937875,"marketCap":71549077},{"date":"2024-02-16","current":-49.912615,"twenty":-5.959596,"median":-4.448819,"eighty":-1.937875,"marketCap":80558961},{"date":"2024-02-23","current":-48.270753,"twenty":-5.960111,"median":-4.478613,"eighty":-1.937875,"marketCap":77908995},{"date":"2024-03-01","current":-54.181458,"twenty":-5.982254,"median":-4.491224,"eighty":-1.938225,"marketCap":87448873},{"date":"2024-03-08","current":-56.808437,"twenty":-6.011873,"median":-4.516354,"eighty":-1.938225,"marketCap":91688818},{"date":"2024-03-15","current":4.043621,"twenty":-6.022006,"median":-4.491224,"eighty":-1.934561,"marketCap":92218811},{"date":"2024-03-22","current":4.086364,"twenty":-6.022006,"median":-4.443439,"eighty":-1.853014,"marketCap":93193610},{"date":"2024-03-28","current":4.133605,"twenty":-6.022006,"median":-4.402047,"eighty":-1.811563,"marketCap":94270993},{"date":"2024-04-05","current":3.991881,"twenty":-6.024673,"median":-4.364031,"eighty":-1.717093,"marketCap":91038844},{"date":"2024-04-12","current":4.039122,"twenty":-6.024673,"median":-4.337431,"eighty":-1.389071,"marketCap":92116227},{"date":"2024-04-19","current":3.473759,"twenty":-6.024673,"median":-4.314454,"eighty":-0.978642,"marketCap":79222546},{"date":"2024-04-26","current":3.379235,"twenty":-6.022006,"median":-4.28696,"eighty":-0.969544,"marketCap":77066831},{"date":"2024-05-03","current":3.804593,"twenty":-6.022006,"median":-4.217087,"eighty":-0.959434,"marketCap":86767551},{"date":"2024-05-10","current":3.993641,"twenty":-6.022006,"median":-4.1681,"eighty":-0.950335,"marketCap":91078982},{"date":"2024-05-17","current":3.615427,"twenty":-6.011873,"median":-4.125993,"eighty":-0.940225,"marketCap":84611835},{"date":"2024-05-24","current":3.408173,"twenty":-6.011873,"median":-4.106805,"eighty":-0.93517,"marketCap":79761475},{"date":"2024-05-31","current":3.275692,"twenty":-6.011873,"median":-4.076207,"eighty":-0.930115,"marketCap":76661027},{"date":"2024-06-07","current":3.24109,"twenty":-6.011873,"median":-4.057326,"eighty":-0.924049,"marketCap":75851227},{"date":"2024-06-14","current":3.137283,"twenty":-6.011873,"median":-4.040347,"eighty":-0.90484,"marketCap":73421829},{"date":"2024-06-21","current":3.160351,"twenty":-5.999311,"median":-4.018,"eighty":-0.890686,"marketCap":73961695},{"date":"2024-06-28","current":2.998873,"twenty":-5.968154,"median":-4.008698,"eighty":-0.869455,"marketCap":70182630},{"date":"2024-07-05","current":3.021942,"twenty":-5.968154,"median":-3.981712,"eighty":-0.859345,"marketCap":70722497},{"date":"2024-07-12","current":3.264158,"twenty":-5.968154,"median":-3.944784,"eighty":-0.828004,"marketCap":76391094},{"date":"2024-07-19","current":3.229556,"twenty":-5.968154,"median":-3.912953,"eighty":-0.80374,"marketCap":75581294},{"date":"2024-07-26","current":3.310295,"twenty":-5.968154,"median":-3.884344,"eighty":-0.766334,"marketCap":77470826},{"date":"2024-08-02","current":3.021942,"twenty":-5.968154,"median":-3.86993,"eighty":-0.754532,"marketCap":70722497},{"date":"2024-08-09","current":3.9635,"twenty":-5.968154,"median":-3.8435,"eighty":-0.748136,"marketCap":69182897},{"date":"2024-08-16","current":3.684817,"twenty":-5.968154,"median":-3.802944,"eighty":-0.731947,"marketCap":64318475},{"date":"2024-08-23","current":4.242184,"twenty":-5.968154,"median":-3.776619,"eighty":-0.710729,"marketCap":74047320},{"date":"2024-08-30","current":4.242184,"twenty":-5.968154,"median":-3.739249,"eighty":-0.687476,"marketCap":74047320},{"date":"2024-09-06","current":4.071877,"twenty":-5.968154,"median":-3.72386,"eighty":-0.673679,"marketCap":71074617},{"date":"2024-09-13","current":4.242184,"twenty":-5.968154,"median":-3.704824,"eighty":-0.639964,"marketCap":74047320},{"date":"2024-09-20","current":4.118324,"twenty":-5.968154,"median":-3.66463,"eighty":-0.624838,"marketCap":71885354},{"date":"2024-09-27","current":4.056395,"twenty":-5.968154,"median":-3.621997,"eighty":-0.619173,"marketCap":70804372},{"date":"2024-10-04","current":4.02543,"twenty":-5.968154,"median":-3.580748,"eighty":-0.611743,"marketCap":70263880},{"date":"2024-10-11","current":3.870606,"twenty":-5.968154,"median":-3.543016,"eighty":-0.608647,"marketCap":67561423},{"date":"2024-10-18","current":3.9635,"twenty":-5.968154,"median":-3.524105,"eighty":-0.598121,"marketCap":69182897},{"date":"2024-10-25","current":4.118324,"twenty":-5.968154,"median":-3.504311,"eighty":-0.580785,"marketCap":71885354},{"date":"2024-11-01","current":3.653852,"twenty":-5.968154,"median":-3.483269,"eighty":-0.498231,"marketCap":63777984},{"date":"2024-11-08","current":4.08736,"twenty":-5.968154,"median":-3.473356,"eighty":-0.412966,"marketCap":71344863},{"date":"2024-11-15","current":18.312392,"twenty":-5.968154,"median":-3.457398,"eighty":-0.380514,"marketCap":64331434},{"date":"2024-11-22","current":18.002013,"twenty":-5.968154,"median":-3.43318,"eighty":-0.355643,"marketCap":63241071},{"date":"2024-11-29","current":17.691633,"twenty":-5.968154,"median":-3.425188,"eighty":-0.337997,"marketCap":62150708},{"date":"2024-12-06","current":18.157203,"twenty":-5.968154,"median":-3.411422,"eighty":-0.328336,"marketCap":63786253},{"date":"2024-12-13","current":16.605305,"twenty":-5.968154,"median":-3.386446,"eighty":-0.310608,"marketCap":58334436},{"date":"2024-12-20","current":14.822174,"twenty":-5.968154,"median":-3.366798,"eighty":-0.299066,"marketCap":52070299},{"date":"2024-12-27","current":15.984546,"twenty":-5.968154,"median":-3.345345,"eighty":-0.294623,"marketCap":56153709},{"date":"2025-01-03","current":17.070874,"twenty":-5.968154,"median":-3.32835,"eighty":-0.282151,"marketCap":59969981},{"date":"2025-01-10","current":15.208597,"twenty":-5.972143,"median":-3.295829,"eighty":-0.27794,"marketCap":53427801},{"date":"2025-01-17","current":14.122269,"twenty":-5.972143,"median":-3.259228,"eighty":-0.270436,"marketCap":49611530},{"date":"2025-01-24","current":13.465816,"twenty":-5.972143,"median":-3.242754,"eighty":-0.26267,"marketCap":47305411},{"date":"2025-01-31","current":13.293555,"twenty":-5.972143,"median":-3.215126,"eighty":-0.252501,"marketCap":46700260},{"date":"2025-02-07","current":12.70073,"twenty":-5.972143,"median":-3.176076,"eighty":-0.248282,"marketCap":44617666},{"date":"2025-02-14","current":12.647966,"twenty":-5.972143,"median":-3.155249,"eighty":-0.245362,"marketCap":44432304},{"date":"2025-02-21","current":12.89627,"twenty":-5.972143,"median":-3.131939,"eighty":-0.243796,"marketCap":45304595},{"date":"2025-02-28","current":12.036518,"twenty":-5.972143,"median":-3.117302,"eighty":-0.239832,"marketCap":42284288},{"date":"2025-03-07","current":12.089283,"twenty":-5.976133,"median":-3.105192,"eighty":-0.225795,"marketCap":42469650},{"date":"2025-03-14","current":12.142047,"twenty":-5.976133,"median":-3.09377,"eighty":2.948123,"marketCap":42655012},{"date":"2025-03-21","current":12.759703,"twenty":-5.976133,"median":-3.09377,"eighty":3.021942,"marketCap":44824835},{"date":"2025-03-28","current":-0.624914,"twenty":-5.976133,"median":-3.09377,"eighty":3.068078,"marketCap":42847841},{"date":"2025-04-04","current":-0.474494,"twenty":-5.976133,"median":-3.09377,"eighty":3.068078,"marketCap":32534173},{"date":"2025-04-11","current":-0.489169,"twenty":-5.972143,"median":-3.092168,"eighty":3.068078,"marketCap":33540384},{"date":"2025-04-17","current":-0.614886,"twenty":-5.972143,"median":-3.092168,"eighty":3.068078,"marketCap":42160263},{"date":"2025-04-25","current":-0.591243,"twenty":-5.976133,"median":-3.09377,"eighty":3.068078,"marketCap":40539144},{"date":"2025-05-02","current":-0.527582,"twenty":-5.976133,"median":-3.075476,"eighty":3.068078,"marketCap":36174184},{"date":"2025-05-09","current":-0.505565,"twenty":-5.976133,"median":-3.045909,"eighty":3.068078,"marketCap":34664597},{"date":"2025-05-16","current":-0.521735,"twenty":-5.976133,"median":-3.016378,"eighty":3.068078,"marketCap":36397827},{"date":"2025-05-23","current":-0.559403,"twenty":-5.976133,"median":-2.968777,"eighty":3.068078,"marketCap":39025627},{"date":"2025-05-30","current":-1.707061,"twenty":-5.976133,"median":-2.956332,"eighty":3.068078,"marketCap":119089665},{"date":"2025-06-06","current":-2.051678,"twenty":-5.976133,"median":-2.924352,"eighty":3.068078,"marketCap":143131240},{"date":"2025-06-13","current":-2.316153,"twenty":-5.976133,"median":-2.884093,"eighty":3.068078,"marketCap":161581752},{"date":"2025-06-20","current":-2.356224,"twenty":-5.980122,"median":-2.858441,"eighty":3.068078,"marketCap":164377284},{"date":"2025-06-27","current":-2.324167,"twenty":-5.980122,"median":-2.838862,"eighty":3.068078,"marketCap":162140858},{"date":"2025-07-03","current":-2.332181,"twenty":-5.980122,"median":-2.780127,"eighty":3.068078,"marketCap":162699965},{"date":"2025-07-11","current":-2.276081,"twenty":-5.980122,"median":-2.754884,"eighty":3.068078,"marketCap":158786220},{"date":"2025-07-18","current":-1.987563,"twenty":-5.980122,"median":-2.664062,"eighty":3.068078,"marketCap":138658389},{"date":"2025-07-25","current":-1.883377,"twenty":-5.980122,"median":-2.492541,"eighty":3.068078,"marketCap":131390006},{"date":"2025-08-01","current":-1.859334,"twenty":-5.980122,"median":-2.383059,"eighty":3.068078,"marketCap":129712687},{"date":"2025-08-08","current":-1.739118,"twenty":-5.980122,"median":-2.350214,"eighty":3.068078,"marketCap":121326090},{"date":"2025-08-15","current":-2.065317,"twenty":-5.980122,"median":-2.324167,"eighty":3.068078,"marketCap":110703069},{"date":"2025-08-22","current":-1.952798,"twenty":-5.980122,"median":-2.324167,"eighty":3.068078,"marketCap":104671918},{"date":"2025-08-29","current":-2.099783,"twenty":-5.980122,"median":-2.284095,"eighty":3.068078,"marketCap":112550450},{"date":"2025-09-05","current":-2.246767,"twenty":-5.980399,"median":-2.249403,"eighty":3.068078,"marketCap":120428981},{"date":"2025-09-12","current":-2.047288,"twenty":-5.980122,"median":-2.211966,"eighty":3.068078,"marketCap":109736688},{"date":"2025-09-19","current":-2.099783,"twenty":-5.980122,"median":-2.174682,"eighty":3.068078,"marketCap":112550450},{"date":"2025-09-26","current":-2.036789,"twenty":-5.980122,"median":-2.152029,"eighty":3.068078,"marketCap":109173936},{"date":"2025-10-03","current":-2.131279,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":114238706},{"date":"2025-10-10","current":-2.477744,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":132809531},{"date":"2025-10-17","current":-2.467245,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":132246778},{"date":"2025-10-24","current":-2.309761,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":123805495},{"date":"2025-10-31","current":-2.477744,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":132809531},{"date":"2025-11-07","current":-2.50924,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":134497787},{"date":"2025-11-14","current":-2.561735,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":137311549},{"date":"2025-11-21","current":-2.904617,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":127326806},{"date":"2025-11-28","current":-3.084549,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":135214308},{"date":"2025-12-05","current":-2.930322,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":128453592},{"date":"2025-12-12","current":-3.020288,"twenty":-5.980122,"median":-2.129376,"eighty":3.068078,"marketCap":132397343}],"updateTime":1765784106836},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586876037","title":"Spero Therapeutics announces inducement grant under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2586876037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586876037?lang=en_us&edition=fundamental","pubTime":"2025-11-28 21:10","pubTimestamp":1764335422,"startTime":"0","endTime":"0","summary":"Spero Therapeutics (SPRO) announced that on November 3, 2025, the Compensation Committee of Spero’s Board of Directors approved the grant of an agg...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spero-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spero-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SQQQ","NQmain","QLD","NVIW.SI","SPRO","BK4139","TSYW.SI","QID","USJW.SI",".IXIC","BK4007","PSQ","BK4539","LENZ","USAW.SI","MNQmain","TQQQ"],"gpt_icon":0},{"id":"2586782769","title":"Spero Therapeutics Grants 90,000 RSUs to New Employee Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2586782769","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586782769?lang=en_us&edition=fundamental","pubTime":"2025-11-28 21:00","pubTimestamp":1764334810,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Inc. has granted 90,000 restricted stock unit awards  to a new employee under its 2019 Inducement Equity Incentive Plan. The RSUs will vest in four equal annual installments beginning on December 1, 2025, contingent on the employee's continued employment with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL52QTmw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO","IE00B64PRP62.GBP","LU2210150020.SGD","BK4112","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD","NDAQ","LU2095319765.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2583512641","title":"Spero Therapeutics Q3 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512641","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512641?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:24","pubTimestamp":1763069052,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Q3 net loss narrowsOverviewSpero Q3 net loss narrowsSpero expects cash reserves to fund operations into 2028OutlookSpero expects cash reserves to fund operations into 2028Result Dri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP18P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"2583884514","title":"BRIEF-Spero Therapeutics Q3 EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2583884514","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583884514?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067949,"startTime":"0","endTime":"0","summary":"BRIEF-Spero Therapeutics Q3 EPS USD -0.13\n\n\nNov 13 (Reuters) - Spero Therapeutics Q3 operating expenses USD 13.358 million.\n\nQ3 income from operation USD -7.916 million\nQ3 net income USD -7.382 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX8739F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"2583511250","title":"Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511250?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUA240WZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"2577843740","title":"Spero Therapeutics Reports Phase 3 Success for Oral Antibiotic Tebipenem HBr in cUTI Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2577843740","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577843740?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026448,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Inc. and GSK plc have announced positive efficacy and safety results from the pivotal Phase 3 PIVOT-PO trial evaluating tebipenem HBr, an investigational oral treatment for complicated urinary tract infections , including pyelonephritis. The results were presented on October 20, 2025, during a late-breaking oral abstract session at IDWeek 2025 in Atlanta, Georgia. The trial met its primary endpoint, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous imipenem-cilastatin. Secondary endpoints showed clinical cure rates of 93.5% for tebipenem HBr and 95.2% for imipenem-cilastatin, as well as similar microbiological response rates. Spero and GSK plan to submit the data to regulatory authorities in Q4 2025. If approved, tebipenem HBr would be the first oral carbapenem antibiotic available in the US for patients with cUTIs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL7vv9hM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210149790.SGD","LU2210150020.SGD","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","SPRO","BK4585","BK4139","IE00B64PRP62.GBP","NDAQ","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2577484595","title":"BRIEF-GSK Announces Full Results Of Positive Pivotal Phase III PIVOT-PO Trial Evaluating Tebipenem HBr","url":"https://stock-news.laohu8.com/highlight/detail?id=2577484595","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577484595?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026407,"startTime":"0","endTime":"0","summary":"BRIEF-GSK Announces Full Results Of Positive Pivotal Phase III PIVOT-PO Trial Evaluating Tebipenem HBrOct 21  - GSK plc GSK.L & Spero Therapeutics SPRO.O :GSK: FULL RESULTS OF POSITIVE PIVOTAL PHASE III PIVOT-PO TRIAL EVALUATING TEBIPENEM HBRGSK: DATA SHOW TEBIPENEM HBR’S POTENTIAL AS FIRST ORAL CARBAPENEM ANTIBIOTIC FOR  COMPLICATED URINARY TRACT INFECTIONSGSK: TRIAL PRIMARY ENDPOINT MET, SHOWING NON-INFERIORITY OF ORAL TEBIPENEM HBR VERSUS IV TREATMENTGSK: SAFETY PROFILE OF TEBIPENEM HBR GENERALLY SIMILAR TO IMIPENEM-CILASTATIN & OTHER CARBAPENEM ANTIBIOTICSGSK: TO WORK WITH U.S. AUTHORITIES TO INCLUDE TEBIPENEM HBR DATA AS PART OF FILING IN Q4Source text: [ID:]Further company coverage: GSK.L ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670756490.USD","GSK.UK","LU0225284248.USD","LU0203345920.USD","LU0211331839.USD","LU1400636574.HKD","LU0971552830.HKD","LU1487256676.USD","LU0321505439.SGD","LU0289739699.SGD","BK4139","LU0306806265.USD","LU1015430645.USD","LU1046248800.SGD","LU0971552673.USD","LU1035777561.USD","LU1481600234.SGD","LU0203347892.USD","LU1098665638.USD","LU1302929846.USD","LU1400636491.USD","IE0034235071.USD","LU1228905540.USD","LU1481599808.USD","LU0161305163.EUR","SPRO","LU0225771236.USD","LU0545562505.USD","LU1645745479.HKD","LU1202635105.USD","LU1309081286.SGD","LU1400636657.SGD","IE00BQJZX424.USD","LU0321505868.SGD","BK5011","LU0575583348.USD","LU1228905037.USD","LU1064927863.SGD","IE00BWDBJ516.SGD","LU0306807586.USD","LU0985481810.HKD","LU0058720904.USD","LU0109981661.USD"],"gpt_icon":0},{"id":"2577843478","title":"GSK: to Work With U.S. Authorities to Include Tebipenem Hbr Data as Part of Filing in Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2577843478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577843478?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU0203345920.USD","LU1487256676.USD","LU0161305163.EUR","LU0225284248.USD","IE0034235071.USD","LU0109981661.USD","LU1645745479.HKD","LU0575583348.USD","LU1015430645.USD","LU1400636574.HKD","SPRO","LU0225771236.USD","BK5011","LU1302929846.USD","LU0971552673.USD","LU0321505439.SGD","LU0971552830.HKD","LU1202635105.USD","LU0306807586.USD","LU1228905540.USD","LU1400636657.SGD","LU0321505868.SGD","LU1228905037.USD","IE00BQJZX424.USD","LU1309081286.SGD","LU0545562505.USD","LU0306806265.USD","LU1670756490.USD","LU0985481810.HKD","LU0203347892.USD","LU1035777561.USD","LU1064927863.SGD","LU0289739699.SGD","LU1098665638.USD","LU1481600234.SGD","GSK.UK","LU1481599808.USD","LU1046248800.SGD","IE00BWDBJ516.SGD","LU1400636491.USD","LU0211331839.USD","BK4139"],"gpt_icon":0},{"id":"2577843423","title":"GSK: Data Show Tebipenem Hbr’s Potential as First Oral Carbapenem Antibiotic for  Complicated Urinary Tract Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2577843423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577843423?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1670756490.USD","LU0161305163.EUR","LU0545562505.USD","GSK.UK","LU0971552673.USD","LU1481599808.USD","LU0211331839.USD","LU0058720904.USD","LU0306806265.USD","LU1487256676.USD","LU0971552830.HKD","LU0289739699.SGD","LU0321505868.SGD","IE00BWDBJ516.SGD","LU1400636491.USD","LU1228905540.USD","LU0225284248.USD","IE0034235071.USD","SPRO","LU1015430645.USD","LU0575583348.USD","LU1035777561.USD","LU1645745479.HKD","LU1202635105.USD","LU0306807586.USD","LU1064927863.SGD","BK4139","LU1046248800.SGD","LU0203345920.USD","LU0203347892.USD","LU0225771236.USD","LU1400636657.SGD","LU1481600234.SGD","BK5011","LU1309081286.SGD","LU0109981661.USD","LU0321505439.SGD","LU1400636574.HKD","LU1228905037.USD","IE00BQJZX424.USD","LU1302929846.USD","LU0985481810.HKD","LU1098665638.USD"],"gpt_icon":0},{"id":"2577843401","title":"GSK: Full Results of Positive Pivotal Phase Iii Pivot-Po Trial Evaluating Tebipenem Hbr","url":"https://stock-news.laohu8.com/highlight/detail?id=2577843401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577843401?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1302929846.USD","LU1487256676.USD","LU0971552830.HKD","LU1228905540.USD","BK4139","LU1481599808.USD","LU0321505439.SGD","LU0985481810.HKD","LU0321505868.SGD","IE00BWDBJ516.SGD","IE00BQJZX424.USD","LU1309081286.SGD","LU0203345920.USD","LU1202635105.USD","LU0225771236.USD","LU0575583348.USD","LU1400636491.USD","LU1015430645.USD","LU1228905037.USD","LU0203347892.USD","GSK.UK","LU1481600234.SGD","LU0306807586.USD","LU1035777561.USD","LU0109981661.USD","LU1645745479.HKD","LU1064927863.SGD","LU0161305163.EUR","LU0058720904.USD","LU0306806265.USD","IE0034235071.USD","LU0289739699.SGD","LU1400636657.SGD","LU0971552673.USD","SPRO","LU1046248800.SGD","LU0545562505.USD","LU0225284248.USD","BK5011","LU1670756490.USD","LU1098665638.USD","LU1400636574.HKD","LU0211331839.USD"],"gpt_icon":0},{"id":"2577434208","title":"GSK: Safety Profile of Tebipenem Hbr Generally Similar to Imipenem-Cilastatin & Other Carbapenem Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577434208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577434208?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505868.SGD","LU0971552830.HKD","IE00BQJZX424.USD","LU0225771236.USD","IE00BWDBJ516.SGD","LU1098665638.USD","LU0203345920.USD","LU1400636657.SGD","LU0545562505.USD","LU1228905540.USD","LU1481599808.USD","LU0289739699.SGD","IE0034235071.USD","LU0109981661.USD","GSK.UK","SPRO","BK5011","LU1400636491.USD","LU1481600234.SGD","BK4139","LU1035777561.USD","LU0321505439.SGD","LU0575583348.USD","LU1202635105.USD","LU1309081286.SGD","LU0306806265.USD","LU0225284248.USD","LU0203347892.USD","LU0161305163.EUR","LU1487256676.USD","LU1015430645.USD","LU1670756490.USD","LU1064927863.SGD","LU0985481810.HKD","LU0211331839.USD","LU1046248800.SGD","LU0306807586.USD","LU1645745479.HKD","LU1400636574.HKD","LU0971552673.USD","LU0058720904.USD","LU1302929846.USD","LU1228905037.USD"],"gpt_icon":0},{"id":"2577239843","title":"GSK: Trial Primary Endpoint Met, Showing Non-Inferiority of Oral Tebipenem Hbr VS Iv Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2577239843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577239843?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:00","pubTimestamp":1761026400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nP8N3MD0H1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1228905037.USD","IE0034235071.USD","LU1670756490.USD","LU0211331839.USD","LU1481599808.USD","LU1064927863.SGD","LU1035777561.USD","LU0289739699.SGD","LU1098665638.USD","SPRO","LU1302929846.USD","LU0971552673.USD","LU1400636491.USD","LU0985481810.HKD","GSK.UK","LU0161305163.EUR","LU0306807586.USD","LU1046248800.SGD","LU0575583348.USD","LU1487256676.USD","BK4139","LU0203345920.USD","LU1400636657.SGD","LU1645745479.HKD","LU0306806265.USD","LU1015430645.USD","LU0321505868.SGD","LU0203347892.USD","LU1309081286.SGD","LU0225771236.USD","IE00BWDBJ516.SGD","LU1202635105.USD","LU0971552830.HKD","LU1481600234.SGD","BK5011","LU0109981661.USD","LU0321505439.SGD","IE00BQJZX424.USD","LU1228905540.USD","LU0058720904.USD","LU0225284248.USD","LU0545562505.USD","LU1400636574.HKD"],"gpt_icon":0},{"id":"2575972682","title":"Spero Therapeutics Announces Positive Phase 3 PIVOT-PO Trial Results for Oral Tebipenem in Complicated Urinary Tract Infections at IDWeek 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575972682","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575972682?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:01","pubTimestamp":1760443260,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Announces Positive Phase 3 PIVOT-PO Trial Results for Oral Tebipenem in Complicated Urinary Tract Infections at IDWeek 2025. Spero Therapeutics Inc., a clinical-stage biopharmaceutical company, announced upcoming presentations on its investigational oral carbapenem, tebipenem Hbr, at the IDWeek annual meeting taking place October 19-22, 2025, in Atlanta, GA. The presentations will include efficacy and safety results from the Phase 3 PIVOT-PO trial evaluating tebipenem Hbr in patients with complicated urinary tract infections , including pyelonephritis. The oral presentation is scheduled for October 20, 2025. Additionally, poster presentations will cover the antibacterial spectrum and activity of tebipenem against Enterobacterales clinical isolates from the United States and United Kingdom, with results to be presented on October 21, 2025. These presentations are being made in collaboration with Spero's development partner, GSK.Disclaimer: This news brief was created ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDLbfDNkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","BK4588","LU2210150020.SGD","LU0314104364.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","NDAQ","LU2210149790.SGD","BK4585","SPRO"],"gpt_icon":0},{"id":"2564936444","title":"Director Ankit Mahadevia Reports Disposal of Common Shares of Spero Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2564936444","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564936444?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:14","pubTimestamp":1756894498,"startTime":"0","endTime":"0","summary":"Ankit Mahadevia, a Director of Spero Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL4Cs1sW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"2564464364","title":"Timothy Keutzer, Chief Operating Officer, Reports Disposal of Spero Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2564464364","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564464364?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:14","pubTimestamp":1756894498,"startTime":"0","endTime":"0","summary":"Timothy Keutzer, Chief Operating Officer of Spero Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL6zVyQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO"],"gpt_icon":0},{"id":"2559629132","title":"Spero Therapeutics Q2 EPS $(0.03) Beats $(0.38) Estimate, Sales $14.189M Up From $10.197M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629132","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629132?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:03","pubTimestamp":1755028989,"startTime":"0","endTime":"0","summary":"Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.38) by 92.11 percent. This is a 90.91 percent increase over losses of $(0.33) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47073473/spero-therapeutics-q2-eps-0-03-beats-0-38-estimate-sales-14-189m-up-from-10-197m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SPRO"],"gpt_icon":0},{"id":"2559629903","title":"BRIEF-Spero Therapeutics Q2 EPS USD -0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629903","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629903?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:01","pubTimestamp":1755028905,"startTime":"0","endTime":"0","summary":"BRIEF-Spero Therapeutics Q2 EPS USD -0.03\n\n\nAug 12 (Reuters) - Spero Therapeutics Q2 income from operation USD -2.444 million.\n\nQ2 operating expenses USD 16.633 million\nQ2 net income USD -1.7 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nPLX89D7E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO"],"gpt_icon":0},{"id":"2558577192","title":"Spero Therapeutics Inc  expected to post a loss of 38 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558577192","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558577192?lang=en_us&edition=fundamental","pubTime":"2025-08-09 05:58","pubTimestamp":1754690287,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Inc  expected to post a loss of38cents a share - Earnings Preview Spero Therapeutics Inc SPRO.OQ SPRO.O is expected to  show a fall in quarterly revenue when it reports  results on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U03PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO"],"gpt_icon":0},{"id":"2556157458","title":"Spero Therapeutics Inc  expected to post a loss of 38 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556157458","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556157458?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:29","pubTimestamp":1754051344,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Inc  expected to post a loss of38cents a share - Earnings Preview Spero Therapeutics Inc SPRO.OQ SPRO.O is expected to  show a fall in quarterly revenue when it reports  results on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL8N3TT1GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO"],"gpt_icon":0},{"id":"2544183931","title":"Spero Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544183931","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544183931?lang=en_us&edition=fundamental","pubTime":"2025-06-19 05:13","pubTimestamp":1750281194,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL5s73p5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}